Immunological findings in neurological diseases associated with antibodies to HTLV-I: activated lymphocytes in tropical spastic paraparesis.

PubWeight™: 1.14‹?› | Rank: Top 10%

🔗 View Article (PMID 2894814)

Published in Ann Neurol on January 01, 1988

Authors

S Jacobson1, V Zaninovic, C Mora, P Rodgers-Johnson, W A Sheremata, C J Gibbs, C Gajdusek, D E McFarlin

Author Affiliations

1: Neuroimmunology Branch, National Institute of Neurological and Communicative Disorders and Stroke, Bethesda, MD 20892.

Articles citing this

Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients. Proc Natl Acad Sci U S A (1998) 1.95

Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-kappaB site. Proc Natl Acad Sci U S A (1998) 1.54

Tax mutation associated with tropical spastic paraparesis/human T-cell leukemia virus type I-associated myelopathy. J Virol (1995) 1.50

Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Retrovirology (2008) 1.45

Human T-cell leukemia-lymphoma virus type I (HTLV-I) expression in fresh peripheral blood mononuclear cells from patients with tropical spastic paraparesis/HTLV-I-associated myelopathy. J Virol (1991) 1.36

Mechanisms of T-cell activation by human T-cell lymphotropic virus type I. Microbiol Mol Biol Rev (1999) 1.27

Spontaneous lymphocyte proliferation in human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infection: T-cell subset responses and their relationships to the presence of provirus and viral antigen production. Clin Diagn Lab Immunol (1994) 1.00

Interactions between brain endothelial cells and human T-cell leukemia virus type 1-infected lymphocytes: mechanisms of viral entry into the central nervous system. J Virol (2000) 0.99

The mitogenic activity of human T-cell leukemia virus type I is T-cell associated and requires the CD2/LFA-3 activation pathway. J Virol (1993) 0.92

Neuroaxonal dystrophy in HTLV-1-associated myelopathy/tropical spastic paraparesis: neuropathologic and neuroimmunologic correlations. Acta Neuropathol (1993) 0.88

IL-10 produced by CD4+ and CD8+ T cells emerge as a putative immunoregulatory mechanism to counterbalance the monocyte-derived TNF-alpha and guarantee asymptomatic clinical status during chronic HTLV-I infection. Clin Exp Immunol (2007) 0.85

Induction of HLA class I and class II expression in human T-lymphotropic virus type I-infected neuroblastoma cells. J Virol (1994) 0.84

Memory lineage relationships in HTLV-1-specific CD8+ cytotoxic T cells. J Neuroimmunol (2006) 0.82

PCR-in situ hybridization detection of human T-cell lymphotropic virus type 1 (HTLV-1) tax proviral DNA in peripheral blood lymphocytes of patients with HTLV-1-associated neurologic disease. J Virol (1996) 0.82

Identification of a domain within the human T-cell leukemia virus type 2 envelope required for syncytium induction and replication. J Virol (1998) 0.81

Spontaneous proliferation of memory (CD45RO+) and naive (CD45RO-) subsets of CD4 cells and CD8 cells in human T lymphotropic virus (HTLV) infection: distinctive patterns for HTLV-I versus HTLV-II. Clin Exp Immunol (1995) 0.79

Evaluation of HTLV-1 activity in HAM/TSP patients using proviral load and Tax mRNA expression after In Vitro lymphocyte activation. Iran J Basic Med Sci (2014) 0.78

Articles by these authors

Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. Proc Natl Acad Sci U S A (1988) 6.74

Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Sträussler syndrome with an analysis of the various forms of amyloid plaque deposition in the virus-induced spongiform encephalopathies. Brain (1981) 5.93

Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee. Science (1968) 5.76

Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol (1979) 5.53

Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol (1994) 5.20

The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med (1996) 5.06

Immunological aspects of demyelinating diseases. Annu Rev Immunol (1992) 4.39

Experimental transmission of a Kuru-like syndrome to chimpanzees. Nature (1966) 4.29

Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies. N Engl J Med (1998) 3.62

Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet (1977) 3.58

Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature (1990) 3.50

Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2- T lymphocytes. J Immunol (1981) 3.15

Real and imagined clinicopathological limits of "prion dementia". Lancet (1993) 2.96

Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1. J Immunol (1991) 2.80

Transmission and passage of experimenal "kuru" to chimpanzees. Science (1967) 2.64

Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein. J Biol Chem (1993) 2.59

Detection of flaviviruses by reverse-transcriptase polymerase chain reaction. J Med Virol (1991) 2.59

Transmissible familial Creutzfeldt-Jakob disease associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene. Proc Natl Acad Sci U S A (1991) 2.55

Detection of cell-dependent cytotoxic antibody to cells infected with herpes simplex virus. Nature (1974) 2.55

The foamy viruses. Bacteriol Rev (1975) 2.53

Ataxia-telangiectasia. Medicine (Baltimore) (1972) 2.50

Pancreatic islets from cyclin-dependent kinase 4/R24C (Cdk4) knockin mice have significantly increased beta cell mass and are physiologically functional, indicating that Cdk4 is a potential target for pancreatic beta cell mass regeneration in Type 1 diabetes. Diabetologia (2004) 2.44

Infection of chimpanzees by human T-lymphotropic retroviruses in brain and other tissues from AIDS patients. Lancet (1985) 2.35

Infection-specific particle from the unconventional slow virus diseases. Science (1984) 2.34

Severe necrotizing cutaneous lesions complicating treatment with interferon beta-1b. N Engl J Med (1995) 2.32

Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated viruses. J Virol (1987) 2.28

Isolation of an HTLV-1-like retrovirus from patients with tropical spastic paraparesis. Nature (1988) 2.27

Early NF-kappaB activation is associated with hormone-induced pancreatitis. Am J Physiol (1998) 2.18

A modified polyriboinosinic-polyribocytidylic acid complex that induces interferon in primates. J Infect Dis (1975) 2.14

Precautions in medical care of, and in handling materials from, patients with transmissible virus dementia (Creutzfeldt-Jakob disease). N Engl J Med (1977) 2.10

Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. N Engl J Med (1985) 2.09

Evidence for widespread infection of wild rats with hepatitis E virus in the United States. Am J Trop Med Hyg (1999) 2.08

HTLV-I and HTLV-III antibodies and tropical spastic paraparesis. Lancet (1985) 2.07

Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J Immunol (1990) 2.07

Diagnosis of Creutzfeldt-Jakob disease by Western blot identification of marker protein in human brain tissue. N Engl J Med (1986) 2.06

Further studies on the specificity of presumed immune associations of myasthenia gravis and consideration of possible pathogenic implications. Ann N Y Acad Sci (1966) 2.02

Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history. Ann Neurol (1991) 2.00

Oral transmission of kuru, Creutzfeldt-Jakob disease, and scrapie to nonhuman primates. J Infect Dis (1980) 1.96

Multiple sclerosis and human T-cell lymphotropic retroviruses. Nature (1985) 1.96

Creutzfeldt-Jakob disease. The neuropathology of a transmission experiment. Brain (1969) 1.96

Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice. Nature (1984) 1.95

Mechanisms of cell death after pancreatic duct obstruction in the opossum and the rat. Gastroenterology (1996) 1.94

An endothelial cell-derived growth factor. J Cell Biol (1980) 1.93

Skewed T-cell receptor repertoire in genetically identical twins correlates with multiple sclerosis. Nature (1993) 1.89

Serotypic classification of hantaviruses by indirect immunofluorescent antibody and plaque reduction neutralization tests. J Clin Microbiol (1985) 1.87

Pancreatic acinar cells produce, release, and respond to tumor necrosis factor-alpha. Role in regulating cell death and pancreatitis. J Clin Invest (1997) 1.84

Relapsing experimental allergic encephalomyelitis in the SJL/J mouse. Lab Invest (1981) 1.84

A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis. J Exp Med (1991) 1.84

Infection as the etiology of spongiform encephalopathy (Creutzfeldt-Jakob disease). Science (1969) 1.83

Subacute spongiform virus encephalopathies. Scrapie, Kuru and Creutzfeldt-Jakob disease: a review. Am J Pathol (1972) 1.81

The familial occurrence of Creutzfeldt-Jakob disease and Alzheimer's disease. Brain (1981) 1.80

Phenotypic variability of Gerstmann-Sträussler-Scheinker disease is associated with prion protein heterogeneity. J Neuropathol Exp Neurol (1998) 1.79

Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J Immunol (1995) 1.76

Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy. N Engl J Med (1985) 1.75

Randomized multicenter trial of natalizumab in acute MS relapses: clinical and MRI effects. Neurology (2004) 1.73

Multiple sclerosis (first of two parts). N Engl J Med (1982) 1.72

Experimental subacute spongiform virus encephalopathies in primates and other laboratory animals. Science (1973) 1.71

Ethanol diet increases the sensitivity of rats to pancreatitis induced by cholecystokinin octapeptide. Gastroenterology (1999) 1.71

Syndromes of amyotrophic lateral sclerosis and dementia: relation to transmissible Creutzfeldt-Jakob disease. Ann Neurol (1983) 1.65

Latent viruses in chimpanzees with experimental kuru. Nature (1967) 1.64

Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and Parkinsonism-dementia of Guam. Science (1982) 1.63

The clinical characteristics of transmissible Creutzfeldt-Jakob disease. Brain (1973) 1.62

Characterization of four new adenovirus serotypes isolated from chimpanzee tissue explants. Am J Epidemiol (1971) 1.61

Experimental spongiform encephalopathy (Creutzfeldt-Jakob disease) in chimpanzees. Electron microscopic studies. J Neuropathol Exp Neurol (1971) 1.60

Thermal stability and conformational transitions of scrapie amyloid (prion) protein correlate with infectivity. Protein Sci (1993) 1.59

Experimental allergic encephalomyelitis: enhancement of cell-mediated transfer by concanavalin A. J Immunol (1977) 1.58

Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol (1993) 1.58

Conduction aphasia. A clinicopathological study. Arch Neurol (1973) 1.57

A new (two-repeat) octapeptide coding insert mutation in Creutzfeldt-Jakob disease. Neurology (1993) 1.55

Acute experimental allergic encephalomyelitis in the mouse: immunopathology of the developing lesion. Cell Immunol (1985) 1.52

Impaired lymphocyte transformation in ataxia-telangiectasia in part due to a plasma inhibitory factor. J Immunol (1969) 1.51

HTLV-1 and polymyositis in Jamaica. Lancet (1989) 1.51

Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis. Ann Neurol (1992) 1.50

New studies on the heat resistance of hamster-adapted scrapie agent: threshold survival after ashing at 600 degrees C suggests an inorganic template of replication. Proc Natl Acad Sci U S A (2000) 1.49

Isolation and characterization of Mycoplasma arginini: spec. nov. Proc Soc Exp Biol Med (1968) 1.49

Chemical disinfection of Creutzfeldt-Jakob disease virus. N Engl J Med (1982) 1.48

Altered plasma membranes in experimental scrapie. Acta Neuropathol (1971) 1.48

The Guillain-Barré syndrome and multiple sclerosis. In vitro cellular responses to nervous-tissue antigens. N Engl J Med (1971) 1.47

Localized pancreatic NF-kappaB activation and inflammatory response in taurocholate-induced pancreatitis. Am J Physiol Gastrointest Liver Physiol (2001) 1.46

Experimentak kuru encephalopathy in chimpanzees and spider monkeysElectron microscopic studies. J Neuropathol Exp Neurol (1969) 1.46

New hemorrhagic fever with renal syndrome-related virus in rodents in the United States. Lancet (1982) 1.46

Amino acid losses during hemodialysis with polyacrylonitrile membranes: effect of intradialytic amino acid supplementation on plasma amino acid concentrations and nutritional variables in nondiabetic patients. Am J Clin Nutr (2000) 1.46

Scrapie in mice: ultrastructural observations in the cerebral cortex. Proc Soc Exp Biol Med (1968) 1.46

Myelopathy among Brazilians coinfected with human T-cell lymphotropic virus type I and HIV. Neurology (1997) 1.45

Measles virus nucleotide sequences: detection by hybridization in situ. Science (1981) 1.45

Identification of human T cell leukemia/lymphoma virus type I antibodies, DNA, and protein in patients with polymyositis. Arthritis Rheum (1995) 1.44

Evidence of endogenous regulatory function of transforming growth factor-beta 1 in experimental allergic encephalomyelitis. Int Immunol (1992) 1.43

Partial characterization of Prospect Hill virus isolated from meadow voles in the United States. J Infect Dis (1985) 1.42

Descriptive epidemiology of Creutzfeldt-Jakob disease in Chile. Arch Neurol (1980) 1.42

Measles antibodies in the cerebrospinal fluid of patients with multiple sclerosis. Proc Soc Exp Biol Med (1971) 1.42

Immunoglobulin A production in ataxia telangiectasia. Science (1965) 1.41

Experimental "kuru" in chimpanzees. A pathological report. Lancet (1966) 1.40

Diversity in fine specificity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106. J Immunol (1992) 1.40

Preclinical lesions and their progression in the experimental spongiform encephalopathies (kuru and Creutzfeldt-Jakob disease) in primates. J Neuropathol Exp Neurol (1977) 1.39

Molecular mass, biochemical composition, and physicochemical behavior of the infectious form of the scrapie precursor protein monomer. Proc Natl Acad Sci U S A (1990) 1.38

An unusual form of diabetes mellitus in ataxia telangiectasia. N Engl J Med (1970) 1.38